Coenzyme Q10 supplements in the ubiquinone form have a proven track record in clinical studies of heart disease. The ubiquinone form increases survival and reduces symptoms in heart failure. It reduces the risk of cardiovascular death. There is no similar evidence for ubiquinol.
Adding CoQ10 supplementation to conventional medication for heart failure is very likely to have a positive effect on survival, on quality of life, on the risk of hospitalization, on physical function, and on the cost-effectiveness of treatment according to a recent analysis.
Normal healthy adults have a CoQ10 status of about 1 mg/L of blood plasma. Heart failure patients benefit from treatment with CoQ10 to raise the plasma level to at least 2.5 mg/L. Aging, mutation in genes, oxidative stress, and statins can all affect the bio-synthesis of CoQ10.
Annually, 6.6 million Americans are diagnosed with heart failure. Adjuvant treatment of heart failure patients with a well-formulated CoQ10 preparation improves patients' heart health and quality of life by enhancing heart muscle bioenergetics and reducing oxidative stress.
Supplementation with Coenzyme Q10 and selenium cuts the risk of death from heart disease in half. The KiSel-10 Study data show that the joint supplementation significantly reduces oxidative stress and inflammation, which are serious factors in the development of atherosclerosis.
Coenzyme Q10 as an adjuvant therapy to the conventional medication for heart failure patients = an idea whose time has come. Patients with [...]
Important to know: Not all Coenzyme Q10 supplements are formulated in the same way. Consequently, the absorption and bio-availability of CoQ10 products can differ [...]
Heart failure – it sounds scary. It is scary, but the medical term heart failure does not mean that your heart stops beating. No, [...]
Fatigue. In many disorders, patients experience fatigue, even extreme fatigue, e.g., heart failure patients, chronic fatigue syndrome and fibromyalgia patients, multiple sclerosis patients, post-treatment [...]
The results from large dog studies done by SIBR Research show that orally administered ubiquinol is mostly converted to the ubiquinone form of Coenzyme [...]
